Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 62

1.

Heterogeneity in Estimates of the Impact of Influenza on Population Mortality: A Systematic Review.

Li L, Wong JY, Wu P, Bond HS, Lau EHY, Sullivan SG, Cowling BJ.

Am J Epidemiol. 2017 Jun 30. doi: 10.1093/aje/kwx270. [Epub ahead of print]

PMID:
28679157
2.

Estimating Influenza Vaccine Effectiveness in the Test-negative Design Using Alternative Control Groups - a Systematic Review and Meta-analysis.

Feng S, Cowling BJ, Kelly H, Sullivan SG.

Am J Epidemiol. 2017 Jun 21. doi: 10.1093/aje/kwx251. [Epub ahead of print]

PMID:
28641373
3.

Influenza vaccination responses: Evaluating impact of repeat vaccination among health care workers.

Leung VK, Carolan LA, Worth LJ, Harper SA, Peck H, Tilmanis D, Laurie KL, Slavin MA, Sullivan SG.

Vaccine. 2017 May 2;35(19):2558-2568. doi: 10.1016/j.vaccine.2017.03.063. Epub 2017 Apr 3.

PMID:
28385605
4.

Consecutive Influenza Infections in Both Adults and Children.

Arnott A, Carville K, Franklin L, Sullivan SG.

J Infect Dis. 2017 Feb 15;215(4):658-659. doi: 10.1093/infdis/jix016. No abstract available.

PMID:
28329041
5.

A brief overview of influenza surveillance systems in Australia, 2015.

Sullivan SG, Raupach J, Franklin LJ, Pennington K, Bareja C, de Kluyver R; and the National Influenza Surveillance Committee, for the Communicable Diseases Network Australia.

Commun Dis Intell Q Rep. 2016 Sep 30;40(3):E351-E355. No abstract available.

PMID:
28278409
6.

Influenza surveillance in Australia.

Pennington K, Bareja C, Sullivan SG, Franklin LJ, Raupach J.

Commun Dis Intell Q Rep. 2016 Sep 30;40(3):E315-E316. No abstract available.

PMID:
28278403
7.

Timely antiretroviral prophylaxis during pregnancy effectively reduces HIV mother-to-child transmission in eight counties in China: a prospective study during 2004-2011.

Wang Q, Wang L, Fang L, Wang A, Jin X, Wang F, Wang X, Qiao Y, Sullivan SG, Rutherford S, Zhang L.

Sci Rep. 2016 Oct 10;6:34526. doi: 10.1038/srep34526.

8.

Theoretical Basis of the Test-Negative Study Design for Assessment of Influenza Vaccine Effectiveness.

Sullivan SG, Tchetgen Tchetgen EJ, Cowling BJ.

Am J Epidemiol. 2016 Sep 1;184(5):345-53. doi: 10.1093/aje/kww064.

PMID:
27587721
9.

Frailty and influenza vaccine effectiveness.

Sullivan SG, Cowling BJ, Greenland S.

Vaccine. 2016 Sep 7;34(39):4645-6. doi: 10.1016/j.vaccine.2016.08.003. No abstract available.

PMID:
27578296
10.

Effectiveness of seasonal influenza vaccine in Australia, 2015: An epidemiological, antigenic and phylogenetic assessment.

Fielding JE, Levy A, Chilver MB, Deng YM, Regan AK, Grant KA, Stocks NP, Sullivan SG.

Vaccine. 2016 Sep 22;34(41):4905-12. doi: 10.1016/j.vaccine.2016.08.067. Epub 2016 Aug 28.

PMID:
27577556
11.

Concordance of interim and final estimates of influenza vaccine effectiveness: a systematic review.

Leung VK, Cowling BJ, Feng S, Sullivan SG.

Euro Surveill. 2016 Apr 21;21(16). doi: 10.2807/1560-7917.ES.2016.21.16.30202. Review.

12.

Influenza vaccine effectiveness by test-negative design - Comparison of inpatient and outpatient settings.

Feng S, Cowling BJ, Sullivan SG.

Vaccine. 2016 Mar 29;34(14):1672-9. doi: 10.1016/j.vaccine.2016.02.039. Epub 2016 Feb 23.

13.

Differential age susceptibility to influenza B/Victoria lineage viruses in the 2015 Australian influenza season.

Barr IG, Vijaykrishna D, Sullivan SG.

Euro Surveill. 2016;21(4). doi: 10.2807/1560-7917.ES.2016.21.4.30118.

14.

How severe was the 2015 influenza season in Australia?

Fielding JE, Regan AK, Dalton CB, Chilver MB, Sullivan SG.

Med J Aust. 2016 Feb 1;204(2):60-1. No abstract available.

PMID:
26821099
15.
16.

"Crude Vaccine Effectiveness" Is a Misleading Term in Test-negative Studies of Influenza Vaccine Effectiveness.

Sullivan SG, Cowling BJ.

Epidemiology. 2015 Sep;26(5):e60. doi: 10.1097/EDE.0000000000000343. No abstract available.

17.

Inter-Seasonal Influenza is Characterized by Extended Virus Transmission and Persistence.

Patterson Ross Z, Komadina N, Deng YM, Spirason N, Kelly HA, Sullivan SG, Barr IG, Holmes EC.

PLoS Pathog. 2015 Jun 24;11(6):e1004991. doi: 10.1371/journal.ppat.1004991. eCollection 2015 Jun.

18.

Influenza viruses with B/Yamagata- and B/Victoria-like neuraminidases are differentially affected by mutations that alter antiviral susceptibility.

Farrukee R, Leang SK, Butler J, Lee RT, Maurer-Stroh S, Tilmanis D, Sullivan S, Mosse J, Barr IG, Hurt AC.

J Antimicrob Chemother. 2015 Jul;70(7):2004-12. doi: 10.1093/jac/dkv065. Epub 2015 Mar 18.

PMID:
25786478
19.

The contrasting phylodynamics of human influenza B viruses.

Vijaykrishna D, Holmes EC, Joseph U, Fourment M, Su YC, Halpin R, Lee RT, Deng YM, Gunalan V, Lin X, Stockwell TB, Fedorova NB, Zhou B, Spirason N, Kühnert D, Bošková V, Stadler T, Costa AM, Dwyer DE, Huang QS, Jennings LC, Rawlinson W, Sullivan SG, Hurt AC, Maurer-Stroh S, Wentworth DE, Smith GJ, Barr IG.

Elife. 2015 Jan 16;4:e05055. doi: 10.7554/eLife.05055.

20.

Who uses methadone services in China? Monitoring the world's largest methadone programme.

Sullivan SG, Wu Z, Rou K, Pang L, Luo W, Wang C, Cao X, Yin W, Liu E, Mi G; National Methadone Maintenance Treatment Working Group.

Addiction. 2015 Jan;110 Suppl 1:29-39. doi: 10.1111/add.12781.

PMID:
25533862

Supplemental Content

Loading ...
Support Center